Cosunter has engaged an EIA institution to prepare the Environmental Influence Assessment Report for Cosunter’s Synthetic Drug Technology Renovation Project (simplified edition). We disclose the preliminary conclusion of this EIA for the project to the public according to the Law of the People's Republic of China on Appraising of Environment and the Temporary Methods of Public Consultation for EIA. The public may download the EIA report (simplified edition) from the website we provide, or obtain more details about this EIA from the company in charge with the following contact information, and send their ideas or suggestions about this EIA in the following ways.
1. The website for downloading the report (simplified edition):
EIA Report of Cosunter’s Active Ingredient Adjustment Project (disclosure finished)
2. Contact information
The company in charge: Fujian Cosunter Pharmaceutical Co., Ltd.
Address: Building 10-B, Area-B Software Park, Software Avenue 89, Gulou District, Fuzhou, Fujian
Contact person: Hu Xiaofei Email: email@example.com
Tel: 0591-38305375 Fax: 0591-28379661
EIA institution: Fujian Provincial Academy of Environmental Science
Address: Building 10, Huanbeisan Village, Tea Garden Community, Fuzhou, 350013
Contact person: Li Gong
Tel: 0591-87712844 Fax: 0591-87739252
3. Approaches and duration allowed for the public to seek for information
(1) Approaches for the public to seek for information
The public may contact the company in charge by E-mail or letter if they need to know more about this EIA.
(2) Duration allowed for the public to seek for information: September 30, 2016 - October 18, 2016
4. Targeted group, content of this consultation and duration allowed
(1) Targeted group: includes stakeholders in this project, different organizations in society, competent authorities in this industry as well as all walks of life.
(2) Content of this consultation: This consultation-oriented activity aims to know the public’s ideas and suggestions about this project in environmental influence and protection. They are hoped to speak their minds objectively.
(3) Duration allowed: The report will be disclosed for ten working days (actually from September 30, 2016 to October 18, 2016). The public may send their ideas and suggestions within five workings days after disclosure (from October 19, 2016 to October 25, 2016).
Disclosed by: Fujian Cosunter Pharmaceutical Co., Ltd.
September 30, 2016